Should you take over InfuSystems Holdings (USA Stocks:INFU) based on newest technical indicators?

INFU Stock  USD 7.70  0.68  9.69%   
As many baby boomers are indifferent towards health care providers & services space, it makes sense to review InfuSystems Holdings against current market trends. As we have suggested previously, InfuSystems Holdings is beginning its drop as private investors shift to be more bearish due to the increased sector volatility. The company returns are related to each other to returns on the market. As market swings up or down, the company is expected to follow. Stable technical and fundamental indicators of the firm may also call for signals of mid-term gains for InfuSystems private investors. InfuSystems Holdings is scheduled to announce its earnings today.
Published over two weeks ago
View all stories for InfuSystems Holdings | View All Stories
Macroaxis uses a strict editorial review process to publish our stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Rifka Kats

The firm's average rating is Strong Buy from 1 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on InfuSystems Holdings market sentiment investors' perception of the future value of InfuSystems. Let us look at a few aspects of InfuSystems technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of InfuSystems Holdings. In general, we focus on analyzing InfuSystems Holdings stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InfuSystems Holdings's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of InfuSystems Holdings's intrinsic value. In addition to deriving basic predictive indicators for InfuSystems Holdings, we also check how macroeconomic factors affect InfuSystems Holdings price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of InfuSystems Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of InfuSystems Holdings in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InfuSystems Holdings. Your research has to be compared to or analyzed against InfuSystems Holdings' peers to derive any actionable benefits. When done correctly, InfuSystems Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in InfuSystems Holdings.

How important is InfuSystems Holdings's Liquidity

InfuSystems Holdings financial leverage refers to using borrowed capital as a funding source to finance InfuSystems Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. InfuSystems Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between InfuSystems Holdings's total debt and its cash.

How does InfuSystems utilize its cash?

To perform a cash flow analysis of InfuSystems Holdings, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash InfuSystems Holdings is receiving and how much cash it distributes out in a given period. The InfuSystems Holdings cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
InfuSystems Holdings Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. InfuSystems Holdings reported Net Cash Flow from Operations of 17.52 Million in 2022

Closer look at InfuSystems Holdings Downside Variance

InfuSystems Holdings has current Downside Variance of 6.81. Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target.

Downside Variance is the probability-weighted squared below-target returns. The squaring of the below-target returns has the effect of penalizing failures at an exponential rate. This is consistent with observations made on the behavior of individual decision-making under.

Downside Variance 
 = 
SUM(RET DEV)2 
N(ER) 
 = 
6.81
SUM = Summation notation
RET DEV = Actual returns deviation over selected period
N(ER) = Number of points with returns less than expected return for the period
Let's now compare InfuSystems Holdings Downside Variance to its closest peers:
INFU
AKYA
ALC
ANGO
ATR
INFU6.810474278747286
AKYA16.4
ALC2.12
ANGO6.01
ATR1.16

Analysis of InfuSystems Holdings

InfuSystems Holdings newest maximum drawdown boosts over 11.52.
As of the 6th of March, InfuSystems Holdings retains the Risk Adjusted Performance of 0.1045, downside deviation of 2.61, and Market Risk Adjusted Performance of 0.2985. InfuSystems Holdings technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for InfuSystems Holdings, which can be compared to its competitors. Please check out InfuSystems Holdings variance, as well as the relationship between the value at risk and skewness to decide if InfuSystems Holdings is priced fairly, providing market reflects its last-minute price of 9.42 per share. Given that InfuSystems Holdings has jensen alpha of 0.2872, we strongly advise you to confirm InfuSystems Holdings's regular market performance to make sure the company can sustain itself at a future point.

Our Final Take On InfuSystems Holdings

Whereas many other companies in the medical instruments & supplies industry are either recovering or due for a correction, InfuSystems may not be as strong as the others in terms of longer-term growth potentials. All things considered, as of the 6th of March 2023, our primary 90 days buy-or-sell advice on the firm is Strong Buy. We believe InfuSystems Holdings is fairly valued with low probability of distress for the next two years.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of InfuSystems Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com